연구동향 분석

Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI

임지연 박은아 송용섭 이활 2018년

논문상세정보
    • 저자 임지연 박은아 송용섭 이활
    • 제어번호 105367295
    • 학술지명 Korean Journal of Radiology
    • 권호사항 Vol. 19 No. 3 [ 2018 ]
    • 발행처 대한영상의학회
    • 자료유형 학술저널
    • 수록면 372-380
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI' 의 참고문헌

  • The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
    Kim RJ [2000]
  • The measurement of observer agreement for categorical data
    Landis JR [1977]
  • Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
    Deray G [2013]
  • Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan
    Ishiguchi T [2010]
  • Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
    Kim RJ [1999]
  • Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement
    Kellman P [2002]
  • Optimizing dose and administration regimen of a high-relaxivity contrast agent for myocardial MRI late gadolinium enhancement
    Secchi F [2011]
  • Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
    Thomsen HS [2007]
  • Nephrogenic fibrosing dermopathy: the first 6 years
    Cowper SE [2003]
  • Nephrogenic fibrosing dermopathy: a comprehensive review for the dermatologist
  • Magnetic resonance imaging: physical principles and sequence design, 1st ed
    Haacke EM [1999]
  • Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine
    Wagner M [2013]
  • MR angiography of the renal arteries: intraindividual comparison of double-dose contrast enhancement at 1.5 T with standard dose at 3 T
    Herborn CU [2008]
  • Low-dose, time-resolved, contrastenhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla
    Kramer U [2010]
  • Late gadolinium enhancement magnetic resonance imaging for the assessment of myocardial infarction: comparison of image quality between single and double doses of contrast agents
    Kim YK [2014]
  • Irreversible myocardial injury: assessment with cardiovascular delayed-enhancement MR imaging and comparison of 1.5 and 3.0 T--initial experience
    Cheng AS [2007]
  • Intraindividual comparison of gadobutrol and gadopentetate dimeglumine for detection of myocardial late enhancement in cardiac MRI
  • Improved detection of subendocardial hyperenhancement in myocardial infarction using dark blood-pool delayed enhancement MRI
    Farrelly C [2011]
  • How we perform delayed enhancement imaging
    Kim RJ [2003]
  • Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease
    Fratz S [2013]
  • Gadoliniumenhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
    Nacif MS [2012]
  • Flow-Independent Dark-blood DeLayed Enhancement (FIDDLE): validation of a novel black blood technique for the diagnosis of myocardial infarction
    Kim HW [2016]
  • Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance
    Flett AS [2011]
  • Dual inversion-recovery mr imaging sequence for reduced blood signal on late gadolinium-enhanced images of myocardial scar
    Peel SA [2012]
  • Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
    Idee JM [2006]
  • Cardiac MRI of ischemic heart disease at 3 T: potential and challenges
    Wieben O [2008]
  • Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla
    Klumpp B [2006]
  • A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age